Evaluation of aortic F-NaF tracer uptake using PET/CT as a predictor of aortic calcification in postmenopausal women: A longitudinal study.

JRSM Cardiovasc Dis

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, Department of Clinical Pharmacology, St Thomas' Hospital.

Published: May 2019

AI Article Synopsis

  • Aortic calcification is linked to arterial stiffening and increased risk of heart-related issues, and F-sodium fluoride (F-NaF) uptake can indicate active calcification areas in the aorta.
  • A study involving 21 postmenopausal women measured F-NaF uptake and aortic calcium volume over approximately 3.8 years, showing an increase in calcium volume but no correlation with the initial F-NaF uptake levels.
  • The findings suggest that F-NaF uptake in the aorta does not effectively predict the progression of aortic calcification in postmenopausal women over the four-year period studied.

Article Abstract

Introduction: Aortic calcification as detected by computed tomography is associated with arterial stiffening and is an important predictor of cardiovascular morbidity and mortality. Uptake of F-sodium fluoride (F-NaF) in the aortic wall reflects metabolically active areas of calcification. The aim of this study was to determine if F-NaF uptake in the aorta is associated with calcification and progression of calcification as detected by computed tomography.

Methods: Twenty-one postmenopausal women (mean age 62 ± 6 years) underwent assessment of aortic F-NaF uptake using positron emission tomography/computer tomography at baseline and a repeat computed tomography scan after a mean follow-up of 3.8 ± 1.3 years. Tracer uptake was quantified by calculating the target-to-background (TBR) ratios at baseline and follow-up. Calcification was assessed at baseline and follow-up using computed tomography.

Results: Over the follow-up period, aortic calcium volume increased from 0.46 ± 0.62 to 0.71 ± 0.93 cm ( < 0.05). However, the change in calcium volume did not correlate with baseline TBR either unadjusted ( = 0.00,  = 1.00) or adjusted for age and baseline calcium volume (beta coefficient = -0.18,  = 0.42). TBR at baseline did not differ between participants with ( = 16) compared to those without ( = 5) progression in calcium volume (2.43 ± 0.46 vs. 2.31 ± 0.38,  = 0.58). In aortic segments identified to have the highest tracer uptake at baseline, calcium volume did not significantly change over the follow-up period ( = 0.41).

Conclusion: In a cohort of postmenopausal women, F-NaF uptake as measured by TBR in the lumbar aorta did not predict progression of aortic calcification as detected by computed tomography over a four-year follow-up.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506920PMC
http://dx.doi.org/10.1177/2048004019848870DOI Listing

Publication Analysis

Top Keywords

aortic f-naf
8
tracer uptake
8
aortic calcification
8
postmenopausal women
8
calcification detected
8
detected computed
8
computed tomography
8
f-naf uptake
8
baseline follow-up
8
calcification
6

Similar Publications

Introduction: As transcatheter aortic valve implantation (TAVI) indications expand, understanding the valve degeneration process and potential influencing biomarkers becomes increasingly important.

Aim: To investigate temporal changes in biomarker levels and their potential association with F-fluorodeoxyglucose (F-FDG) and F-sodium fluoride (F-NaF) uptake, assessed using positron emission tomography/computed tomography (PET/CT) studies as markers for native aortic annulus calcifications and early-stage TAVI valve degeneration.

Material And Methods: A total of 71 TAVI patients underwent blood sampling and transthoracic echocardiography at baseline (pre-TAVI) and 6, 12, 18, and 24 months after the procedure.

View Article and Find Full Text PDF

Performance of simplified methods for quantification of [F]NaF uptake in fibrodysplasia ossificans progressiva.

Front Nucl Med

July 2024

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, Netherlands.

Article Synopsis
  • Fibrodysplasia Ossificans Progressiva (FOP) is a rare disease that causes bones to form in places where they shouldn't, like muscles and tendons.
  • A study looked at how well different methods can measure this unnatural bone growth in seven patients by using a special scan called [F]NaF PET/CT.
  • The results showed that one method called TBR worked best for figuring out how much fluoride was taken up in the patients' bodies, especially over a year of monitoring.
View Article and Find Full Text PDF

Deep Learning Model of Diastolic Dysfunction Risk Stratifies the Progression of Early-Stage Aortic Stenosis.

JACC Cardiovasc Imaging

September 2024

Division of Cardiovascular Diseases and Hypertension, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA. Electronic address:

Article Synopsis
  • The study explores how a deep learning model can predict the risk of developing aortic stenosis (AS) from the early stage of aortic valve sclerosis by assessing diastolic dysfunction (DD).
  • Researchers evaluated data from 898 participants in the ARIC cohort and validated their findings in two other groups, showing a significant correlation between high DD risk and the development of AS or related health interventions.
  • The results indicate that using deep learning to measure DD effectively stratifies risk in patients, providing a better understanding of how AS progresses.
View Article and Find Full Text PDF

Effect of Evogliptin on the Progression of Aortic Valvular Calcification.

J Am Coll Cardiol

September 2024

Division of Cardiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.

Article Synopsis
  • The study explored whether evogliptin, a dipeptidyl peptidase-4 inhibitor, could slow the progression of aortic stenosis (AS) in 228 patients over 96 weeks, measuring changes in aortic valve calcium volume (AVCV).
  • Results showed no significant reduction in AVCV for either dosage of evogliptin compared to placebo; however, evogliptin groups had significantly lower active calcification volume at 48 weeks using F-sodium fluoride PET.
  • Although evogliptin did not appear to protect against AV calcification, the study suggests the potential for longer-term benefits, indicating a need for larger trials to confirm these findings.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates whether the uptake of F-FDG and F-NaF can predict the expansion of abdominal aortic aneurysms in a rat model, highlighting a correlation between imaging uptake and pathological markers.
  • The research involved 74 male rats and monitored changes in aortic size and imaging metrics over a period of 8 weeks, with effects from different medications assessed.
  • Results indicated that F-FDG and F-NaF uptake varied over time, with specific drugs influencing these changes, and showed that F-NaF uptake at 1 week was the strongest predictor of final aortic size, suggesting potential for these imaging techniques in monitoring aneurysm progression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!